Literature DB >> 15188938

Lipoprotein(a): new insights into mechanisms of atherogenesis and thrombosis.

Arjun Deb1, Noel M Caplice.   

Abstract

Lipoprotein(a) (Lp[a]) continues to be a controversial molecule regarding its role in human vascular disease. Although the physiologic role of this molecule is still unclear, novel discoveries within the last few years have suggested numerous mechanisms whereby Lp(a) may contribute to atherosclerosis and its complications in human subjects. These effects may differentially occur in vascular tissue and circulating blood compartments. A complex interplay between tissue-specific effects is probably more relevant to the pathogenicity of this molecule than one single effect alone. This review briefly describes the structure of Lp(a) in relation to its biochemical function, summarizing the current literature on various pathophysiologic mechanisms of Lp(a)-induced vascular disease and the role of cell and tissue-specific effects in promoting atherogenesis and thrombosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188938      PMCID: PMC6654090          DOI: 10.1002/clc.4960270503

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  15 in total

Review 1.  Genetics of Dyslipidemia and Ischemic Heart Disease.

Authors:  Kavita Sharma; Ragavendra R Baliga
Journal:  Curr Cardiol Rep       Date:  2017-05       Impact factor: 2.931

2.  Coronary atherosclerosis, low-density lipoproteins and markers of thrombosis, inflammation and endothelial dysfunction.

Authors:  Thomas F Whayne
Journal:  Int J Angiol       Date:  2007

Review 3.  Discovery and validation of new molecular targets in treating dyslipidemia: the role of human genetics.

Authors:  Amit V Khera; Daniel J Rader
Journal:  Trends Cardiovasc Med       Date:  2009-08       Impact factor: 6.677

4.  A survival case of a young adult patient with ST-elevated myocardial infarction with high levels of lipoprotein(a).

Authors:  Hiroaki Hiraiwa; Ryota Morimoto; Takahiro Okumura; Yoshihito Arao; Hideo Oishi; Hiroo Kato; Shogo Yamaguchi; Tasuku Kuwayama; Tomoaki Haga; Tsuyoshi Yokoi; Toru Kondo; Naoki Watanabe; Takayuki Mitsuda; Kenji Fukaya; Akinori Sawamura; Akihito Tanaka; Hideki Ishii; Itsuro Morishima; Hideyuki Tsuboi; Toyoaki Murohara
Journal:  J Cardiol Cases       Date:  2019-03-08

5.  Relation of Plasma Lipoprotein(a) to Subclinical Coronary Plaque Volumes, Three-Vessel and Left Main Coronary Disease, and Severe Coronary Stenoses in Apparently Healthy African-Americans With a Family History of Early-Onset Coronary Artery Disease.

Authors:  Brian G Kral; Rita R Kalyani; Lisa R Yanek; Dhananjay Vaidya; Elliot K Fishman; Diane M Becker; Lewis C Becker
Journal:  Am J Cardiol       Date:  2016-07-05       Impact factor: 2.778

6.  Oxidized Phospholipids and Risk of Calcific Aortic Valve Disease: The Copenhagen General Population Study.

Authors:  Pia R Kamstrup; Ming-Yow Hung; Joseph L Witztum; Sotirios Tsimikas; Børge G Nordestgaard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-06-01       Impact factor: 8.311

Review 7.  Regulation of cholesterol homeostasis in health and diseases: from mechanisms to targeted therapeutics.

Authors:  Yajun Duan; Ke Gong; Suowen Xu; Feng Zhang; Xianshe Meng; Jihong Han
Journal:  Signal Transduct Target Ther       Date:  2022-08-02

Review 8.  Evolving concepts of the vulnerable atherosclerotic plaque and the vulnerable patient: implications for patient care and future research.

Authors:  Prakriti Gaba; Bernard J Gersh; James Muller; Jagat Narula; Gregg W Stone
Journal:  Nat Rev Cardiol       Date:  2022-09-23       Impact factor: 49.421

9.  Lipoprotein(a) levels predict adverse vascular events after acute myocardial infarction.

Authors:  Takayuki Mitsuda; Yusuke Uemura; Hideki Ishii; Kenji Takemoto; Tomohiro Uchikawa; Masayoshi Koyasu; Shinji Ishikawa; Ayako Miura; Ryo Imai; Satoshi Iwamiya; Yuta Ozaki; Tomohiro Kato; Rei Shibata; Masato Watarai; Toyoaki Murohara
Journal:  Heart Vessels       Date:  2016-03-02       Impact factor: 2.037

10.  Lipoprotein(a) is associated with necrotic core progression of non-culprit coronary lesions in statin-treated patients with angina pectoris.

Authors:  Tsuyoshi Nozue; Shingo Yamamoto; Shinichi Tohyama; Kazuki Fukui; Shigeo Umezawa; Yuko Onishi; Tomoyuki Kunishima; Akira Sato; Toshihiro Nozato; Shogo Miyake; Youichi Takeyama; Yoshihiro Morino; Takao Yamauchi; Toshiya Muramatsu; Kiyoshi Hibi; Mitsuyasu Terashima; Ichiro Michishita
Journal:  Lipids Health Dis       Date:  2014-04-01       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.